Phase Ib/II Study of Leronlimab (PRO 140) Combined with Carboplatin in Patients with CCR5+ Metastatic Triple-Negative Breast Cancer (mTNBC)

Project: Clinical Trial

Project Details

StatusActive
Effective start/end date11/8/19 → …